TNF and psoriasis: The authors found that the repetitive application of ItP of TNF-α drug etanercept (recombinant human TNF-α receptor: Fc fusion protein) on imiquimod (IMQ)-induced psoriasis skin significantly reduced the pathogenesis of psoriasis.